ENTACAPONE and SOMNOLENCE

Overview

SOMNOLENCE is the #11 most commonly reported adverse reaction for ENTACAPONE, manufactured by Ajanta Pharma USA Inc.. There are 190 FDA adverse event reports linking ENTACAPONE to SOMNOLENCE. This represents approximately 1.7% of all 11,238 adverse event reports for this drug.

Patients taking ENTACAPONE who experience somnolence should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

SOMNOLENCE is a less commonly reported adverse event for ENTACAPONE, but still significant enough to appear in the safety profile.

Other Side Effects of ENTACAPONE

In addition to somnolence, the following adverse reactions have been reported for ENTACAPONE:

• DYSKINESIA — 461 reports
• HALLUCINATION — 459 reports
• FALL — 443 reports
• DRUG INEFFECTIVE — 332 reports
• DEATH — 318 reports
• PARKINSON^S DISEASE — 274 reports
• CONFUSIONAL STATE — 255 reports
• GAIT DISTURBANCE — 253 reports
• TREMOR — 251 reports
• ON AND OFF PHENOMENON — 225 reports

Other Drugs Associated with SOMNOLENCE

The following drugs have also been linked to somnolence in FDA adverse event reports:

Does ENTACAPONE cause SOMNOLENCE?

SOMNOLENCE has been reported as an adverse event in 190 FDA reports for ENTACAPONE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is SOMNOLENCE with ENTACAPONE?

SOMNOLENCE accounts for approximately 1.7% of all adverse event reports for ENTACAPONE, making it a notable side effect.

What should I do if I experience SOMNOLENCE while taking ENTACAPONE?

If you experience somnolence while taking ENTACAPONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages